The prognostic significance of heparanase in pediatric HL patients was demonstrated by a 6-fold increase in heparanase level at diagnosis and a subsequent decrease associated with complete remission (CR) or a good partial response (Table 2) [66, 67]. This evidence concerns the gene HPSE and Hodgkins lymphoma.